Exp Clin Endocrinol Diabetes 2008; 116 - P37
DOI: 10.1055/s-0028-1096364

Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1112 patients – the German interdisciplinary database

HJ Schneider 1, M Schneider 2, I Kreitschmann-Andermahr 3, U Tuschy 4, H Wallaschofski 5, M Faust 6, C Renner 7, A Kopczak 2, M Jordan 8, B Saller 9, M Buchfelder 10, GK Stalla 11
  • 1Medizinische Klinik – Innenstadt, University of Munich, Germany
  • 2Neurologische Klinik Bad Aibling, Germany
  • 3Department of Neurosurgery, University of Aachen, Germany
  • 4Department of Internal Medicine, Erfurt, Germany
  • 5Department of Gastroenterology, Endocrinology and Nutrition, University of Greifswald, Germany
  • 6Department of Endocrinology, University of Koeln, Germany
  • 7Klinik und Poliklinik für Neurochirurgie, Universität Leipzig, Germany
  • 8ClinSupport, Erlangen, Germany
  • 9Pfizer Global Pharmaceuticals, Walton Oaks, UK
  • 10Department of Neurosurgery, University of Erlangen, Germany
  • 11Neuroendocrinology Group, Max Planck Institute of Psychiatry, Munich, Germany

Aims: Recent studies show that traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH) are frequent causes of long-term disturbances of hypothalamo-pituitary function. Still, little is known about risk factors and clinical characteristics of pituitary impairment after brain damage. This study aims to address these questions on a larger scale by establishing a national registry of these patients. Methods: Several large trauma centers in Germany treating patients with TBI or SAH and performing endocrine assessments include patients in this on-going investigation. Data are collected using a structured, internet-based study sheet, obtaining information on clinical, radiological and hormonal parameters. Results: To date, 1112 patients (725 TBI, age 43.5±19.7 years; 378 SAH, 49.7±11.8 years) have been included. Stimulation tests for the corticotropic and somatotropic axes were performed in 26% and 22% of the patients, respectively. In patients with known pituitary function, hypopituitarism was reported in 28% and 27% after TBI and SAH, respectively. According to the frequency of impairment, pituitary hormone secretion was impaired the following sequence: ACTH, LH/FSH, GH, and TSH. Conclusions: Our data confirm that hypopituitarism is a common complication of TBI and SAH, also when using data obtained from a large and unselected patient cohort. However, we can not exclude a certain selection bias for performing endocrine stimulation tests only in more severely traumatized patients.